Dietary potassium-enriched salt strategy shows potential in resistant hypertension :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Potassium-enriched salt replacement linked to improved 24-hour BP outcomes

Blood pressure Blood pressure
Blood pressure Blood pressure

What's new?

Switching from regular dietary salt to a potassium-based substitute improves blood pressure control in individuals with resistant hypertension.

Lifestyle-based interventions, particularly sodium restriction and potassium enrichment, are increasingly recognized as valuable supportive strategies for managing blood pressure (BP). However, evidence assessing potassium-enriched salt substitutes specifically in resistant arterial hypertension (RAH) remains restricted. Researchers therefore investigated whether replacing regular dietary salt with a potassium-enriched salt substitute could improve ambulatory blood pressure monitoring (ABPM) while maintaining safety in adults with RAH.

Investigators conducted a randomized, double-blind, controlled pilot trial involving adults diagnosed with RAH. Participants were randomly assigned to receive either a potassium-enriched salt substitute containing approximately equal proportions of sodium chloride and potassium chloride or conventional table salt over a 24-week intervention period. The primary endpoint focused on changes in :

  • 24-hour systolic blood pressure measured through ABPM
  • Additional assessments included:
    1. Diastolic BP trends
    2. Office BP readings
    3. Urinary electrolyte excretion
    4. Safety outcomes like hyperkalemia and adverse events

Analytical comparisons between groups were performed to minimize the effects of white-coat variability and regression toward the mean. Among the 60 participants initially randomized, 49 completed both baseline and follow-up ABPM evaluations.

  • Patients receiving the potassium-enriched salt substitute experienced a greater reduction in 24-hour systolic BP compared with those consuming regular salt, with a between-group difference of −2.47 mmHg, with similar directional improvements in diastolic BP.
  • Urinary potassium excretion increased notably in the intervention group, suggesting successful dietary potassium enrichment. Urinary sodium reduction remained relatively modest.
  • Office BP readings displayed greater variability and were less consistent than ambulatory measurements throughout the study period.
  • Importantly, no clinically significant hyperkalemia or serious treatment-related adverse events were reported during the trial.

The pilot study suggested that potassium-enriched salt substitution may serve as a practical and well-tolerated adjunctive strategy for managing RAH. Researchers concluded that replacing conventional salt with a potassium-rich alternative shows encouraging BP-lowering potential without major safety concerns.

Source:

Contemporary Clinical Trials

Article:

The impact of a potassium-enriched salt substitute on blood pressure control in patients with resistant arterial hypertension: A randomized pilot trial

Authors:

Enilson Carmo Barbosa dos Santos et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: